Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7884197 Synthetic agonists of TLR9

Patent 7884197 was granted and assigned to Idera Pharmaceuticals on February, 2011 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

Idera Pharmaceuticals

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Mallikarjuna Putta0

Sudhir Agrawal0

Daqing Wang0

Dong Yu0

Ekambar Kandimalla0

Lakshmi Bhagat0

Date of Patent

February 8, 2011

0

Patent Application Number

119547260

Date Filed

December 12, 2007

0

Patent Citations Received

US Patent 11957788 Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications

0

Patent Primary Examiner

0

Patent abstract

The invention provides novel oligonucleotide-based compounds that individually provide distinct immune response profiles through their interactions as agonists with TLR9. The TLR9 agonists according to the invention are characterized by specific and unique chemical modifications, which provide their distinctive immune response activation profiles.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7884197 Synthetic agonists of TLR9

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.